Materias dentro de su búsqueda.
Mostrando 421 - 440 Resultados de 1,900 Para Buscar '"AstraZeneca"', tiempo de consulta: 1.94s Limitar resultados
  1. 421
    “…Ambrose, MD, MBA, AstraZeneca (Employee, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1401. Real-World Effectiveness of Inactivated and Live Attenuated Influenza Vaccines in Children During Three Recent Seasons: 2016–2019
  2. 422
    “…Ambrose, MD, MBA, AstraZeneca (Employee, Shareholder) Ravi Jhaveri, MD, AbbVie (Grant/Research Support)Alios (Research Grant or Support)Gilead (Grant/Research Support)Medimmune/AstraZeneca (Employee)Merck (Grant/Research Support)Saol Therapeutics (Consultant)Seqirus (Consultant)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1395. Influenza B-Associated Pediatric Mortality in the US Between 2010 and 2019
  3. 423
    “…We present the case of a 24-year-old female who developed pituitary apoplexy following the second dose of an AstraZeneca COVID-19 vaccine. CLINICAL CASE: A 24-year-old female presented with sudden onset of severe frontal headache, a day after receiving her second AstraZeneca vaccine dose. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ODP289 A rare case of COVID-19 vaccine-associated pituitary apoplexy
  4. 424
    “…DISCLOSURES: Reynold Panettieri, Jr., MD, AstraZeneca: Advisor/Consultant|AstraZeneca: Grant/Research Support|AstraZeneca: Honoraria|Equillium: Grant/Research Support|Genentech: Advisor/Consultant|Genentech: Grant/Research Support|Janssen: Grant/Research Support|MedImmune: Grant/Research Support|Merck: Honoraria|Novartis: Grant/Research Support|Origo: Grant/Research Support|RIFM: Advisor/Consultant|RIFM: Grant/Research Support|Sanofi: Honoraria|Vault Health: Grant/Research Support Jane A. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB1531A. Administration of abatacept, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial.
  5. 425
    “…Research Investigator; Self; AstraZeneca, Boehringer Ingelheim, Indigo Diabetes, Novo Nordisk. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    THU066 An 8-year Interim Report Of The B2412 Study, An Open-label, Multicenter Pasireotide Rollover Study For Patients Who Continued To Receive Benefit From Pasireotide At Completion Of An Earlier Trial
  6. 426
    por Gouvea, Maria da Penha Gomes, Moula, Isac Ribeiro, Gouveia, Thayná Martins, Thompson, Beatriz Paoli, Lança, Karen Evelin Monlevade, Lacerda, Gabriela Curto Cristianes, Lenzi, João Pedro Gonçalves, Ramos, Sabrina de Souza, Lacerda, Barbara Sthefany de Paula, Forechi, Ludimila, Filho, Olindo Assis Martins, de Carvalho, Andréa Teixeira, Camacho, Luiz Antonio Bastos, Villela, Daniel Antunes Maciel, Pinto Neto, Lauro, Faé, Filipe, Moulin, Anna Carolina Simões, de Barros, Arthur Prando, Souza, Bárbara Oliveira, Surlo, Heitor Filipe, Vieira, Gabriel Smith Sobral, de Lima, Marina Deorce, Pasti, Laís Pizzol, Grillo, Luiza Lorenzoni, Aguiar, Laura Gonçalves Rodrigues, Athayde, Paula, Lorencini, Pietra Zava, Ribeiro, Hellen Carvalho, Soares, Cinthia Eduarda Santos, Macabú, Mariana, Albertino, Laíssa Fiorotti, Miossi, João Pedro Moraes, Rassele, Matheus Leite, Pimentel, Felipe de Castro, Henriques, Allan Gonçalves, Amaral, Maria Eduarda Moraes Hibner, Machado, Ketty Lysie Libardi Lira, Mill, José Geraldo, Valim, Valéria
    Publicado 2022
    “…Em relação ao grupo de AstraZeneca o pico foi 5617, ± 6101,8 AU/mL. CONCLUSÃO: A reatividade humoral induzida pelas vacinas AstraZeneca e CoronaVac foi alta, com taxa de soroconversão de 100% com os dois imunizantes após a segunda dose. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    REATIVIDADE VACINAL E DURAÇÃO DE RESPOSTA IMUNE DA CORONAVAC E ASTRAZENECA EM UMA COORTE DE TRABALHADORES
  7. 427
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Recruiting the Immune System Against Disease: Lessons for Clinical and Systems Pharmacology
  8. 428
    “…[Figure: see text] DISCLOSURES: Graf:  MorphoSys: Consultancy, Research Funding; TG Therapeutics: Research Funding; AstraZeneca: Research Funding; BeiGene: Research Funding; GSK: Research Funding. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Oral Ixazomib in Untreated Follicular Lymphoma Permits COVID-19 Vaccine Response and Its Efficacy Is Associated with Clinical Factors and Gene Expression Signatures
  9. 429
    “…OBJECTIVES: This meta-analysis evaluated the Efficacy and Effectiveness of several COVID-19 vaccines, including AstraZeneca, Pfizer, Moderna, Bharat, and Johnson & Johnson, to better estimate their immunogenicity, benefits, or side effects. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis
  10. 430
    “…DISCLOSURES: Simon Pollett, MBBS, AstraZeneca: The IDCRP and the Henry M. Jackson Foundation (HJF) were funded to conduct an unrelated phase III COVID-19 monoclonal antibody immunoprophylaxis trial Timothy Burgess, MD, MPH, AstraZeneca: The IDCRP and the Henry M. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2651. Successful Sequencing and Genotyping of SARS-CoV-2 and Influenza Viruses from Self-Collected Nasal Swabs for SARS-CoV-2 Rapid Antigen Testing
  11. 431
    “…DISCLOSURES: David Tribble, MD, DrPH, AstraZeneca: The IDCRP and HJF were funded to conduct an unrelated phase III COVID-19 monoclonal antibody immunoprophylaxis trial as part of US Govt COVID response Timothy Burgess, MD, MPH, AstraZeneca: The IDCRP and the Henry M. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2349. Natural Killer Cells and BNT162b2 mRNA Vaccine Reactogenicity and Durability
  12. 432
    Publicado 1999
    Electrónico Procedimiento de la Conferencia eBook
    Congreso Extraordinario del 50ª Aniversario de la Sociedad Española de Otorrinolaringología y Patología = 50th Anniversary Extraordinary Congress
  13. 433
    por Wapenaar, Jeroen
    Publicado 2021
    “…Dat gebeurt grotendeels met het vaccin van AstraZeneca en de universiteit van Oxford. Wat moet je daarover weten?…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    8 vragen over het AstraZenecavaccin
  14. 434
    “…Additionally, the participants had myalgia (37.2%), fever (30.8%), chills (29.2%), local reactions (26.0%), and headache (24.4%) after the third dose of the vaccine. CONCLUSION: AstraZeneca had a higher proportion of post-vaccination adverse effects than Sputnik V, Pastocovac, and Sinopharm. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Side effects after COVID-19 vaccination: a comparison between the most common available vaccines in Iran
  15. 435
    “…Finally, the intranasal liposomal formulation boosted heterologous immunity induced by previous intramuscular vaccination with the Oxford/AstraZeneca vaccine, which was more robust than homologous immunity.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection
  16. 436
    “…S.M. has received sponsorship from Otsuka and Lundbeck to attend an academic congress and owns shares in GlaxoSmithKline and AstraZeneca. J.H. has attended meetings supported by Sunovion Pharmaceuticals.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Maintenance antipsychotic treatment versus discontinuation strategies following remission from first episode psychosis: systematic review
  17. 437
    “…Here we perform a high-throughput screen of AstraZeneca’s 1.3 million in-house compound library and identify 5 novel chemotypes with faster in vitro kill rates (<2 days) than existing anti-Wolbachia drugs that cure onchocerciasis and lymphatic filariasis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides
  18. 438
    “…The monoclonal antibodies bamlanivimab and etesivimab, which are used therapeutically, are ineffective. The AstraZeneca vaccine offers almost no protection against mild or moderate disease caused by the beta variant. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID-19: Epidemiologie und Mutationen: Ein Update
  19. 439
    “…Background: The Oxford–AstraZeneca vaccine (Covishield) was the first to be introduced in Bangladesh to fight the ongoing global COVID-19 pandemic. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Retrospective Cross-Sectional Study Assessing Self-Reported Adverse Events following Immunization (AEFI) of the COVID-19 Vaccine in Bangladesh
  20. 440
    “…COVID-19 vaccination began in São Paulo, Brazil in January 2021, first targeting healthcare workers (HCWs) and the elderly, using the CoronaVac vaccine (Sinovac/Butantan) and subsequently the Oxford/AstraZeneca (ChAdOx1) vaccine (AstraZeneca/FIOCRUZ-RJ). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil
Herramientas de búsqueda: RSS